The Effectiveness of Online Group Dialectical Behavioral Therapy on Bulimia Nervosa
1 other identifier
interventional
120
1 country
1
Brief Summary
Bulimia Nervosa (BN) is a kind of chronic refractory mental disorder with high prevalence and relapse rate, which would cause serious damage to physical and mental health. Dialectical Behavioral Therapy (DBT) is an internationally effective and evidence-based therapy for BN patients. Previous studies have found that DBT group therapy can significantly improve the core symptoms of BN patients. Our research group has conducted DBT group therapy for BN, and found that after 12 weeks of treatment, the frequencies of binge eating and purging behavior of BN patients were significantly reduced. However, with the high cost of ground-based group therapy and low coverage, it is difficult to promote the G-DBT(Group Dialectical Behavioral Therapy) for BN, considering the shortage of mental health resource in China. Besides, videoconferencing-based psychotherapy has gradually emerged in recent years. However, there is still a lack of clinical studies on the videoconferencing-based G-DBT for BN at home and abroad to confirm its efficacy and feasibility. Therefore, this study intends to use a randomized controlled study by randomly allocating BN patients into videoconferencing-based G-DBT group and traditional G-DBT group for 12 weeks. By comparing the changes of core symptoms and psychological characteristics of BN patients before and after treatment, this study aims to illustrate the efficacy and feasibility of videoconferencing-based G-DBT is no less than traditional G-DBT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2020
CompletedFirst Submitted
Initial submission to the registry
August 11, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2023
CompletedFirst Posted
Study publicly available on registry
August 17, 2026
CompletedAugust 25, 2026
August 1, 2026
2 years
August 11, 2022
August 22, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Changes of binge eating and purging episodes from baseline
Measured by Eating Disorder Examination Questionnaire (EDE-Q, item 13 and 15). Core pathological behaviors of BN patients.
Baseline, week 12 (end of the treatment), week 16 and week 24
Secondary Outcomes (6)
Change of disordered eating from baseline
Baseline, week 12 (end of the treatment), week 16 and week 24
Changes of eating disorder related cognitive and behavioral characteristics
Baseline, week 12 (end of the treatment), week 16 and week 24
Change of impulse control ability
Baseline, week 12 (end of the treatment), week 16 and week 24
Change of depression level
Baseline, week 12 (end of the treatment), week 16 and week 24
Change of anxiety level
Baseline, week 12 (end of the treatment), week 16 and week 24
- +1 more secondary outcomes
Study Arms (2)
online G-DBT
EXPERIMENTALParticipants receive the G-DBT via videoconference weekly.
face-to-face G-DBT
ACTIVE COMPARATORParticipants attend the traditional G-DBT weekly in Shanghai Mental Health Center.
Interventions
Online G-DBT is an adapted version of G-DBT delivered via video-conference. The specific design of G-DBT is the same as traditional face-to-face G-DBT. It also consists of 12 sessions, which is conducted weekly and lasts for 120 minutes. There are two therapists in charge of the therapy.
The G-DBT consists of 12 sessions, each lasting 120 minutes, and is held once a week. Two DBT therapists lead the patients to learn mindfulness skills, emotion regulation skills, pain tolerance skills, and interpersonal effectiveness skills. The aim is to help the patients reduce binge eating and harmful behaviors by regulating their emotions. Each sessions is conducted in a face-to-face way, in the psychological therapy room of the outpatient clinic in Shanghai Mental Health Center.
Eligibility Criteria
You may qualify if:
- Female, 18-35 years old, right-handed;
- Education level is junior high school or above;
- Meet the Diagnostic criteria of Bulimia Nervosa in DSM-5 (The diagnostic and statistical manual of mental disorders,DSM), body mass index (BMI)≥18.5 kg/m2;
- Did not receive systematic nutritional therapy, psychiatric drug therapy or any form of psychological therapy within 1 month before enrollment;
- Able to understand the study and agree to participate.
You may not qualify if:
- Those who meet other DSM-5 diagnoses besides BN, such as substance abuse/dependence, depression, bipolar disorder, anxiety disorder, obsessive-compulsive disorder, etc. And those with high risk of suicide, strong disruptive impulse or antisocial behavior.
- Patients with serious primary or secondary physical disease, cognitive impairment, so that they can not complete the required assessment.
- Have received systematic nutritional therapy, individual and group psychotherapy previously.
- Have taken neuroblockers, antidepressants, lithium salts, stimulants, antiepileptic drugs and other psychotropic drugs within the past 1 month.
- For other reasons that researchers consider it inappropriate to participate in this clinical trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanghai Mental Health Center
Shanghai, 200030, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jue Chen, PhD
Shanghai Mental Health Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief Physician, Department Director
Study Record Dates
First Submitted
August 11, 2022
First Posted
August 17, 2026
Study Start
December 1, 2020
Primary Completion
November 30, 2022
Study Completion
November 30, 2023
Last Updated
August 25, 2026
Record last verified: 2026-08